Log In
BCIQ
Print this Print this
 

GD2-targeted CAR-T cells

  Manage Alerts
Collapse Summary General Information
Company Beijing Sinobioway Group Co. Ltd.
Description Chimeric antigen receptor (CAR) T cells targeting ganglioside GD2 (GD2)
Molecular Target Ganglioside GD2 (GD2)
Mechanism of Action 
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I/II
Standard IndicationNeuroendocrine tumors
Indication DetailsTreat refractory or relapsed neuroblastoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today